{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:16:52Z","timestamp":1791505012242,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s11596-025-00001-x","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T06:33:32Z","timestamp":1740465212000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of Helicobacter pylori Eradication on Clinical and Laboratory Parameters in Non-alcoholic Fatty Liver Disease Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials"],"prefix":"10.1007","volume":"45","author":[{"given":"Fouad","family":"Jaber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saqr","family":"Alsakarneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azizullah","family":"Beran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tala","family":"Alsharaeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed-Jordan","family":"Salahat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahman","family":"Abdelshafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islam","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willie","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Elfert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Jaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Almeqdadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Ghoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendell K.","family":"Clarkston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Helzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"issue":"12","key":"1_CR1","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1111\/j.1572-0241.2008.02151.x","volume":"103","author":"T Gunji","year":"2008","unstructured":"Gunji T, Matsuhashi N, Sato H, et al. Helicobacter pylori infection is significantly associated with metabolic syndrome in the Japanese population. Am J Gastroenterol. 2008;103(12):3005\u20133010.","journal-title":"Am J Gastroenterol"},{"key":"1_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.833424","volume":"13","author":"L Wang","year":"2022","unstructured":"Wang L, Cao ZM, Zhang LL, et al. Helicobacter Pylori and Autoimmune Diseases: Involving Multiple Systems. Front Immunol. 2022;13:833424.","journal-title":"Front Immunol"},{"issue":"6","key":"1_CR3","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S2468-1253(22)00008-5","volume":"7","author":"LA D\u00edaz","year":"2022","unstructured":"D\u00edaz LA, Fuentes-L\u00f3pez E, Ayares G, et al. The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas. Lancet Gastroenterol Hepatol. 2022;7(6):552\u2013559.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"41","key":"1_CR4","doi-asserted-by":"publisher","first-page":"7024","DOI":"10.3748\/wjg.v19.i41.7024","volume":"19","author":"M Li","year":"2013","unstructured":"Li M, Shen Z, Li YM. Potential role of Helicobacter pylori infection in nonalcoholic fatty liver disease. World J Gastroenterol, 2013,19(41):7024\u20137031.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"1_CR5","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/j.1523-5378.2009.00668.x","volume":"14","author":"H Cheng","year":"2009","unstructured":"Cheng H, Hu FL, Lian Zhang L, et al. Prevalence of Helicobacter pylori Infection and Identification of Risk Factors in Rural and Urban Beijing, China. Helicobacter. 2009;14(2):128\u2013133.","journal-title":"Helicobacter"},{"issue":"8776","key":"1_CR6","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/0140-6736(91)92035-Z","volume":"338","author":"AC Wotherspoon","year":"1991","unstructured":"Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, et al. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet. 1991;338(8776):1175\u20131176.","journal-title":"Lancet"},{"issue":"9","key":"1_CR7","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1080\/00365520510023251","volume":"40","author":"P Stalke","year":"2005","unstructured":"Stalke P, Al-Soud WA, Bielawski KP, et al. Detection of Helicobacter species in liver and stomach tissues of patients with chronic liver diseases using polymerase chain reaction-denaturing gradient gel electrophoresis and immunohistochemistry. Scand J Gastroenterol. 2005;40(9):1032\u20131041.","journal-title":"Scand J Gastroenterol"},{"issue":"7","key":"1_CR8","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1007\/s10620-008-0522-5","volume":"54","author":"T Pirouz","year":"2009","unstructured":"PirouzT, ZounubiL, Keivani H, et al. Detection of Helicobacter pylori in paraffin-embedded specimens from patients with chronic liver diseases, using the amplification method. Dig Dis Sci. 2009;54(7):1456\u20131459.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"1_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/MEG.0b013e3282efa4f2","volume":"20","author":"M Cindoruk","year":"2008","unstructured":"Cindoruk M, Cirak MY, Unal S, et al. Identification of Helicobacter species by 16SrDNA PCR and sequence analysis in human liver samples from patients with various etiologies of benign liver diseases. Eur J Gastroenterol Hepatol. 2008;20(1):33\u201336.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"12","key":"1_CR10","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1136\/jcp.2004.018556","volume":"57","author":"Y Huang","year":"2004","unstructured":"Huang Y, Fan XG, Wang ZM, et al. Identification of helicobacter species in human liver samples from patients with primary hepatocellular carcinoma. J Clin Pathol. 2004;57(12):1273\u20131277.","journal-title":"J Clin Pathol"},{"issue":"2","key":"1_CR11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1054\/mehy.1999.0987","volume":"54","author":"A Ponzetto","year":"2000","unstructured":"Ponzetto A, Pellicano R, Leone N, et al. Helicobacter infection and cirrhosis in hepatitis C virus carriage: is it an innocent bystander or a troublemaker? Med Hypotheses. 2000;54(2):275\u2013277.","journal-title":"Med Hypotheses"},{"issue":"6","key":"1_CR12","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.cdp.2003.07.004","volume":"27","author":"N Leone","year":"2003","unstructured":"Leone N, Pellicano R, Brunello F, et al. Helicobacter pylori seroprevalence in patients with cirrhosis of the liver and hepatocellular carcinoma. Cancer Detect Prev. 2003;27(6):494\u2013497.","journal-title":"Cancer Detect Prev"},{"issue":"12","key":"1_CR13","doi-asserted-by":"publisher","first-page":"14679","DOI":"10.5812\/hepatmon.14679","volume":"13","author":"R Jamali","year":"2013","unstructured":"Jamali R, MofidA, Vahedi H, et al. The effect of helicobacter pylori eradication on liver fat content in subjects with non-alcoholic Fatty liver disease: a randomized open-label clinical trial. Hepat Mon. 2013;13(12):14679.","journal-title":"Hepat Mon"},{"issue":"1","key":"1_CR14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.metabol.2012.06.007","volume":"62","author":"SA Polyzos","year":"2013","unstructured":"PolyzosSA, Kountouras J, Papatheodorou A, et al. Helicobacter pylori infection in patients with nonalcoholic fatty liver disease. Metabolism. 2013;62(1):121\u2013126.","journal-title":"Metabolism"},{"issue":"4","key":"1_CR15","first-page":"549","volume":"136","author":"S Thirumurthi","year":"2012","unstructured":"Thirumurthi S, Graham DY. Helicobacter pylori infection in India from a western perspective. Indian J Med Res. 2012;136(4):549\u2013562.","journal-title":"Indian J Med Res"},{"issue":"3","key":"1_CR16","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1128\/CMR.00054-05","volume":"19","author":"JG Kusters","year":"2006","unstructured":"Kusters JG, van Vliet AHM, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev. 2006;19(3):449\u2013490.","journal-title":"Clinical Microbiology Reviews"},{"issue":"Suppl 1","key":"1_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000051918","volume":"63","author":"Y Fukuda","year":"2001","unstructured":"Fukuda Y, Bamba H, Okui M, et al. Helicobacter pylori infection increases mucosal permeability of the stomach and intestine. Digestion. 2001;63(Suppl 1):93\u201396.","journal-title":"Digestion"},{"issue":"1","key":"1_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1099\/00222615-42-1-48","volume":"42","author":"NS Taylor","year":"1995","unstructured":"Taylor NS, Fox G, Yan L. In-vitro hepatotoxic factor in Helicobacter hepaticus, H. pylori and other Helicobacter species. J Med Microbiol. 1995;42(1):48\u201352.","journal-title":"J Med Microbiol"},{"issue":"5","key":"1_CR19","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.1523-5378.2009.00705.x","volume":"14","author":"T Gunji","year":"2009","unstructured":"Gunji T, Matsuhashi N, Sato H, et al. Helicobacter pylori infection significantly increases insulin resistance in the asymptomatic Japanese population. Helicobacter. 2009;14(5):144\u2013150.","journal-title":"Helicobacter"},{"issue":"5","key":"1_CR20","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1136\/gut.52.5.637","volume":"2","author":"CU Nwokolo","year":"2003","unstructured":"Nwokolo CU, Freshwater DA, O'Hare P, et al. Plasma ghrelin following cure of Helicobacter pylori. Gut. 2003;2(5):637\u2013640.","journal-title":"Gut"},{"issue":"13","key":"1_CR21","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1001\/archinte.165.13.1552","volume":"165","author":"MS Wu","year":"2005","unstructured":"Wu MS, Lee WJ, Wang HH, et al. A case-control study of association of Helicobacter pylori infection with morbid obesity in Taiwan. Arch Intern Med. 2005;165(13):1552\u20131555.","journal-title":"Arch Intern Med"},{"issue":"3","key":"1_CR22","first-page":"362","volume":"38","author":"Y Takuma","year":"2011","unstructured":"Takuma Y. Helicobacter pylori infection and liver diseases. Gan To Kagaku Ryoho (Japanese). 2011;38(3):362\u2013364.","journal-title":"Gan To Kagaku Ryoho (Japanese)"},{"issue":"4","key":"1_CR23","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264\u2013269.","journal-title":"Ann Intern Med"},{"issue":"1","key":"1_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"7","author":"AR Jadad","year":"1996","unstructured":"Jadad AR, Moore RA, Carroll D. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;7(1):1\u201312.","journal-title":"Control Clin Trials"},{"key":"1_CR25","unstructured":"Higgins JPT, Thomas J, Chandler J, et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated February 2022). Cochrane, 2022. Available from: www.training.cochrane.org\/handbook."},{"issue":"2","key":"1_CR26","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/gastro\/goz058","volume":"8","author":"V Maharshi","year":"2020","unstructured":"Maharshi V, Gupta P, Kumar VL, et al. Effect of Helicobacter pylori-eradication therapy on hepatic steatosis in patients with non-alcoholic fatty liver disease: a randomized-controlled pilot study. Gastroenterol Rep (Oxf). 2020;8(2):104\u2013110.","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"1","key":"1_CR27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s43066-019-0001-z","volume":"9","author":"AM Kazemifar","year":"2019","unstructured":"Kazemifar AM, Shafikhani AA, Hajinoormohammadi E, et al. Investigating effect of Helicobacter pylori treatment on improvement of non-alcoholic fatty liver parameters: a randomized trial. Egyptian Liver J. 2019;9(1):2.","journal-title":"Egyptian Liver J"},{"issue":"1","key":"1_CR28","doi-asserted-by":"publisher","first-page":"19530","DOI":"10.1038\/s41598-022-23746-0","volume":"12","author":"YY Yu","year":"2022","unstructured":"Yu YY, Tong YL, Wu LY, et al. Helicobacter pylori infection eradication for nonalcoholic fatty liver disease: a randomized controlled trial. Sci Rep. 2022;12(1):19530.","journal-title":"Sci Rep"},{"issue":"3","key":"1_CR29","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1590\/S0004-28032014000300017","volume":"51","author":"SA Polyzos","year":"2014","unstructured":"Polyzos SA, Nikolopoulos P, Stogianni A, et al. Effect of Helicobacter pylori eradication on hepatic steatosis, NAFLD fibrosis score and HSENSI in patients with nonalcoholic steatohepatitis: a MR imaging-based pilot open-label study. Arq Gastroenterol. 2014;51(3):261\u2013268.","journal-title":"Arq Gastroenterol"},{"key":"1_CR30","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3389\/fmicb.2017.00743","volume":"8","author":"DD Cheng","year":"2017","unstructured":"Cheng DD, He C, Ai HH, et al. The Possible Role of Helicobacter pylori Infection in Non-alcoholic Fatty Liver Disease. Front Microbiol. 2017;8:743.","journal-title":"Front Microbiol"},{"issue":"11","key":"1_CR31","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.4254\/wjh.v13.i11.1688","volume":"13","author":"MA Kalas","year":"2021","unstructured":"Kalas MA, Chavez L, Leon M, et al. Abnormal liver enzymes: A review for clinicians. World J Hepatol. 2021;13(11):1688\u20131698.","journal-title":"World J Hepatol"},{"key":"1_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.716783","volume":"8","author":"V Houttu","year":"2021","unstructured":"HouttuV, Csader S, NieuwdorpM, et al. Dietary Interventions in Patients with Non-alcoholic Fatty Liver Disease: Awithtematic Review and Meta-Analysis. Front Nutr. 2021;8:716783.","journal-title":"Front Nutr"},{"issue":"2","key":"1_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0263931","volume":"17","author":"T Fern\u00e1ndez","year":"2022","unstructured":"Fern\u00e1ndez T, Vi\u00f1uela M, Vidal C, et al. Lifestyle changes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis. PLoS One. 2022;17(2):e0263931.","journal-title":"PLoS One"},{"issue":"10","key":"1_CR34","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3390\/nu9101065","volume":"9","author":"GD Pepa","year":"2017","unstructured":"Pepa GD, Vetrani C, Lombardi G, et al. Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals. Nutrients. 2017;9(10):1065.","journal-title":"Nutrients"},{"issue":"11","key":"1_CR35","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.ultrasmedbio.2010.07.005","volume":"36","author":"M Sasso","year":"2010","unstructured":"Sasso M, Beaugrand M, De Ledinghen V, et al. Controlled attenuation parameter (CAP): a novel VCTE\u2122 guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol. 2010;36(11):1825\u20131835.","journal-title":"Ultrasound Med Biol"},{"issue":"6","key":"1_CR36","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/j.1478-3231.2012.02820.x","volume":"32","author":"V de L\u00e9dinghen","year":"2012","unstructured":"de L\u00e9dinghen V, Vergniol J, Foucher J, et al. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography. Liver Int. 2012;32(6):911\u2013918.","journal-title":"Liver Int"}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-025-00001-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-025-00001-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-025-00001-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T19:03:46Z","timestamp":1741892626000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-025-00001-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1"],"URL":"https:\/\/doi.org\/10.1007\/s11596-025-00001-x","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"22 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All other authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted according to the Declaration of Helsinki statement.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}